BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3487141)

  • 61. Trifluoroethanol-induced beta --> alpha transition in beta-lactoglobulin: hydration and cosolvent binding studied by 2H, 17O, and 19F magnetic relaxation dispersion.
    Kumar S; Modig K; Halle B
    Biochemistry; 2003 Nov; 42(46):13708-16. PubMed ID: 14622017
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Native-like beta-structure in a trifluoroethanol-induced partially folded state of the all-beta-sheet protein tendamistat.
    Schönbrunner N; Wey J; Engels J; Georg H; Kiefhaber T
    J Mol Biol; 1996 Jul; 260(3):432-45. PubMed ID: 8757805
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
    Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
    Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [The effect of heparin on the process of colony formation from bone marrow mononuclears in a diffusion chamber].
    Popov GK; Bel'skiĭ MS; Pochinskiĭ AG
    Farmakol Toksikol; 1991; 54(5):33-5. PubMed ID: 1800143
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow.
    Mumcuoglu M; Naparstek E; Slavin S
    Bone Marrow Transplant; 1990 Mar; 5(3):153-8. PubMed ID: 2184907
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bone marrow reactions to E. coli endotoxin or Pseudomonas original endotoxin protein in germ-free mice.
    Yoshida M; Hirata M; Homma JY; Abe C; Tajima Y
    Jpn J Exp Med; 1976 Oct; 46(5):297-303. PubMed ID: 827626
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Amifostine-mediated protection of normal bone marrow from cytotoxic chemotherapy.
    Capizzi RL; Scheffler BJ; Schein PS
    Cancer; 1993 Dec; 72(11 Suppl):3495-501. PubMed ID: 8242582
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 2,2,2-Trifluoroethanol-induced enteropathy in rats: chemically or bacterially mediated effects.
    Kim JC; Fraser JM; Samsonoff WA; Kaminsky LS; Shin SJ
    Toxicol Pathol; 1987; 15(4):388-400. PubMed ID: 3324284
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Metabolism of 2,2,2-trifluoroethanol and its relationship to toxicity.
    Fraser JM; Kaminsky LS
    Toxicol Appl Pharmacol; 1987 Jun; 89(2):202-10. PubMed ID: 3603557
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 2,2,2-Trifluoroethanol intestinal and bone marrow toxicity: the role of its metabolism to 2,2,2-trifluoroacetaldehyde and trifluoroacetic acid.
    Fraser JM; Kaminsky LS
    Toxicol Appl Pharmacol; 1988 Jun; 94(1):84-92. PubMed ID: 3376117
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Acute toxicity of fluorinated ether anesthetics: role of 2,2,2-trifluoroethanol and other metabolites.
    Murphy MJ; Dunbar DA; Kaminsky LS
    Toxicol Appl Pharmacol; 1983 Oct; 71(1):84-92. PubMed ID: 6138883
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Trifluorinated ether anesthetic lethality in rats: the role of bacterial infection.
    Dersham G; McMartin D; Dunbar D; Kaminsky L
    Toxicol Appl Pharmacol; 1983 Oct; 71(1):93-100. PubMed ID: 6138884
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mechanism of toxicity of 2,2,2-trifluoroethanol in rats.
    Fraser JM; Silkworth JB; Kaminsky LS
    Toxicol Appl Pharmacol; 1986 Jun; 84(1):84-92. PubMed ID: 3487141
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Multiple aspects of the toxicity of fluroxene and its metabolite 2,2,2-trifluoroethanol.
    Kaminsky LS; Fraser JM
    Crit Rev Toxicol; 1988; 19(2):87-112. PubMed ID: 2906849
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.